Share Price and Basic Stock Data
Last Updated: November 7, 2025, 6:39 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Bilcare Ltd operates in the packaging and containers sector, focusing on providing innovative solutions for various industries. The company reported sales of ₹982 Cr for the fiscal year ending March 2023, a decrease from ₹1,127 Cr in the previous fiscal year. Quarterly sales figures from March 2022 to September 2023 showed fluctuations, with the highest sales of ₹255.69 Cr recorded in March 2022. However, by June 2023, sales had declined to ₹182.25 Cr, indicating a notable drop in demand. The most recent quarterly sales for September 2023 stood at ₹189.92 Cr, suggesting a slight recovery. Despite the challenges, Bilcare’s revenue from operations per share showed a slight increase to ₹334.69 in March 2025 from ₹317.34 in March 2024. The company’s focus on maintaining operational efficiency is evident as it navigates market dynamics and strives to regain its growth trajectory.
Profitability and Efficiency Metrics
Profitability metrics for Bilcare Ltd present a mixed picture. The company’s operating profit margin (OPM) stood at 3.81% for the fiscal year ending March 2025, reflecting a decline from previous years. Notably, operating profit was reported at ₹45 Cr for the fiscal year 2025, down from ₹57 Cr in 2023. The net profit for the same fiscal year recorded a slight recovery to ₹5.04 Cr, following a significant loss of ₹19.67 Cr in March 2024. The interest coverage ratio (ICR) was reported at 0.76x, indicating challenges in covering interest expenses, which stood at ₹18.49 Cr for March 2025. The cash conversion cycle (CCC) was reported at 78 days, which is relatively high compared to industry standards, potentially impacting liquidity. Overall, while there are signs of recovery in net profit, the company’s profitability remains under pressure amid fluctuating sales and rising costs.
Balance Sheet Strength and Financial Ratios
Bilcare Ltd’s balance sheet reflects a challenging financial position, characterized by total borrowings of ₹682 Cr against reserves of ₹445 Cr as of March 2025. The company has a debt-to-equity ratio of 1.43x, indicating a reliance on borrowed funds, which may pose risks in a rising interest rate environment. The book value per share, excluding revaluation reserves, was reported at ₹199.21, providing a buffer against market volatility. The return on equity (ROE) stood at a modest 5.58%, while the return on capital employed (ROCE) was reported at 1.10%, both of which are relatively low compared to industry benchmarks. Furthermore, the price-to-book value (P/BV) ratio of 0.46x suggests that the stock is trading below its intrinsic value, potentially indicating undervaluation. The company’s total assets decreased to ₹1,417 Cr in March 2025, down from ₹1,593 Cr in the previous year, reflecting a contraction in asset base.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Bilcare Ltd reveals a stable structure, with promoters holding 30.01% of the equity as of March 2025. Foreign institutional investors (FIIs) have a negligible stake of 0.04%, while the public holds 69.95% of the shares. The number of shareholders has declined to 17,047, down from 23,236 in September 2022, indicating a potential decrease in retail investor confidence. The lack of significant institutional interest may raise concerns regarding the stock’s liquidity and overall market perception. Despite these challenges, the consistent promoter holding suggests a commitment to the company’s long-term prospects. The stability in public shareholding could serve as a foundation for future growth if operational performance improves. However, the declining number of shareholders may signal caution among investors about the company’s recovery trajectory.
Outlook, Risks, and Final Insight
Bilcare Ltd faces several risks that could impact its future performance. The ongoing volatility in sales and profitability, alongside a high debt burden, poses significant challenges. The company must address operational efficiencies and cost management to enhance profitability. Additionally, fluctuations in raw material prices and changes in consumer demand could further strain financial performance. On the upside, a successful turnaround strategy focused on innovation in packaging solutions could enable Bilcare to capture market share and improve profitability. If the company can stabilize its operations and regain investor confidence, it may see a resurgence in shareholder interest and stock performance. Conversely, failure to address these challenges could lead to further declines in profitability and market perception. Overall, Bilcare’s journey ahead will necessitate strategic focus and robust execution to navigate its current financial landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Bilcare Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Tin Works Ltd | 139 Cr. | 134 | 225/128 | 10.4 | 207 | 0.60 % | 7.95 % | 5.88 % | 10.0 |
| Gujarat Containers Ltd | 98.9 Cr. | 175 | 191/160 | 14.4 | 94.4 | 0.86 % | 18.4 % | 17.4 % | 10.0 |
| Goblin India Ltd | 19.5 Cr. | 14.1 | 35.0/12.5 | 10.0 | 31.2 | 0.00 % | 7.73 % | 4.63 % | 10.0 |
| G K P Printing & Packaging Ltd | 17.4 Cr. | 7.93 | 10.4/4.85 | 23.0 | 10.2 | 0.00 % | 4.87 % | 3.87 % | 10.0 |
| Garware Hi Tech Films Ltd | 7,908 Cr. | 3,404 | 5,378/2,317 | 24.3 | 1,021 | 0.35 % | 20.6 % | 15.0 % | 10.0 |
| Industry Average | 1,957.70 Cr | 336.89 | 66.32 | 181.42 | 0.31% | 12.76% | 24.70% | 7.38 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 255.69 | 248.13 | 254.03 | 245.86 | 233.59 | 182.25 | 189.92 | 174.94 | 200.07 | 194.14 | 201.74 | 198.13 | 194.03 |
| Expenses | 236.93 | 232.26 | 239.57 | 233.84 | 219.16 | 168.79 | 173.22 | 157.69 | 208.33 | 175.20 | 194.09 | 187.48 | 186.64 |
| Operating Profit | 18.76 | 15.87 | 14.46 | 12.02 | 14.43 | 13.46 | 16.70 | 17.25 | -8.26 | 18.94 | 7.65 | 10.65 | 7.39 |
| OPM % | 7.34% | 6.40% | 5.69% | 4.89% | 6.18% | 7.39% | 8.79% | 9.86% | -4.13% | 9.76% | 3.79% | 5.38% | 3.81% |
| Other Income | 5.13 | 2.68 | 9.61 | -6.46 | 231.29 | 2.75 | 0.56 | 3.76 | 8.82 | 3.74 | -6.02 | -6.47 | 21.16 |
| Interest | 16.95 | 15.82 | 16.44 | 16.36 | 11.38 | 19.00 | 19.66 | 20.54 | 22.59 | 20.85 | 23.68 | 19.48 | 18.49 |
| Depreciation | 9.45 | 9.43 | 9.44 | 9.64 | 9.30 | 10.50 | 10.48 | 10.57 | 13.40 | 11.52 | 11.04 | 11.74 | 11.58 |
| Profit before tax | -2.51 | -6.70 | -1.81 | -20.44 | 225.04 | -13.29 | -12.88 | -10.10 | -35.43 | -9.69 | -33.09 | -27.04 | -1.52 |
| Tax % | 38.25% | -11.49% | 59.67% | -5.87% | 65.22% | -1.13% | -5.36% | 34.06% | -44.48% | 55.01% | -9.55% | -39.90% | -431.58% |
| Net Profit | -3.47 | -5.93 | -2.89 | -19.24 | 78.28 | -13.14 | -12.19 | -13.54 | -19.67 | -15.02 | -29.93 | -16.25 | 5.04 |
| EPS in Rs | -2.48 | -2.84 | -2.42 | -7.98 | 19.63 | -3.36 | -3.22 | -2.91 | -4.63 | -2.71 | -6.81 | -3.05 | 4.48 |
Last Updated: May 31, 2025, 6:42 am
Below is a detailed analysis of the quarterly data for Bilcare Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 194.03 Cr.. The value appears to be declining and may need further review. It has decreased from 198.13 Cr. (Dec 2024) to 194.03 Cr., marking a decrease of 4.10 Cr..
- For Expenses, as of Mar 2025, the value is 186.64 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 187.48 Cr. (Dec 2024) to 186.64 Cr., marking a decrease of 0.84 Cr..
- For Operating Profit, as of Mar 2025, the value is 7.39 Cr.. The value appears to be declining and may need further review. It has decreased from 10.65 Cr. (Dec 2024) to 7.39 Cr., marking a decrease of 3.26 Cr..
- For OPM %, as of Mar 2025, the value is 3.81%. The value appears to be declining and may need further review. It has decreased from 5.38% (Dec 2024) to 3.81%, marking a decrease of 1.57%.
- For Other Income, as of Mar 2025, the value is 21.16 Cr.. The value appears strong and on an upward trend. It has increased from -6.47 Cr. (Dec 2024) to 21.16 Cr., marking an increase of 27.63 Cr..
- For Interest, as of Mar 2025, the value is 18.49 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 19.48 Cr. (Dec 2024) to 18.49 Cr., marking a decrease of 0.99 Cr..
- For Depreciation, as of Mar 2025, the value is 11.58 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.74 Cr. (Dec 2024) to 11.58 Cr., marking a decrease of 0.16 Cr..
- For Profit before tax, as of Mar 2025, the value is -1.52 Cr.. The value appears strong and on an upward trend. It has increased from -27.04 Cr. (Dec 2024) to -1.52 Cr., marking an increase of 25.52 Cr..
- For Tax %, as of Mar 2025, the value is -431.58%. The value appears to be improving (decreasing) as expected. It has decreased from -39.90% (Dec 2024) to -431.58%, marking a decrease of 391.68%.
- For Net Profit, as of Mar 2025, the value is 5.04 Cr.. The value appears strong and on an upward trend. It has increased from -16.25 Cr. (Dec 2024) to 5.04 Cr., marking an increase of 21.29 Cr..
- For EPS in Rs, as of Mar 2025, the value is 4.48. The value appears strong and on an upward trend. It has increased from -3.05 (Dec 2024) to 4.48, marking an increase of 7.53.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:45 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,062 | 2,692 | 2,603 | 2,633 | 2,778 | 2,997 | 1,827 | 623 | 845 | 982 | 747 | 788 | 780 |
| Expenses | 2,819 | 2,506 | 2,396 | 2,443 | 2,617 | 2,827 | 1,782 | 572 | 784 | 925 | 708 | 743 | 744 |
| Operating Profit | 243 | 186 | 207 | 190 | 161 | 170 | 45 | 51 | 60 | 57 | 39 | 45 | 37 |
| OPM % | 8% | 7% | 8% | 7% | 6% | 6% | 2% | 8% | 7% | 6% | 5% | 6% | 5% |
| Other Income | 24 | 9 | -87 | 107 | 297 | 59 | 254 | 45 | 44 | 237 | 16 | 12 | 15 |
| Interest | 217 | 236 | 151 | 176 | 249 | 283 | 174 | 76 | 69 | 60 | 82 | 82 | 80 |
| Depreciation | 141 | 191 | 164 | 177 | 416 | 378 | 239 | 46 | 39 | 38 | 45 | 46 | 46 |
| Profit before tax | -91 | -232 | -194 | -56 | -207 | -433 | -114 | -25 | -4 | 196 | -72 | -71 | -75 |
| Tax % | 25% | -7% | -58% | 42% | -4% | 5% | -13% | -55% | 3% | 74% | -18% | -21% | |
| Net Profit | -114 | -216 | -82 | -80 | -199 | -453 | -99 | -11 | -4 | 50 | -59 | -56 | -51 |
| EPS in Rs | -48.14 | -91.76 | -36.04 | -35.91 | -85.43 | -193.28 | -43.97 | -8.95 | -5.35 | 6.39 | -14.12 | -12.23 | -6.96 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -89.47% | 62.04% | 2.44% | -148.75% | -127.64% | 78.15% | 88.89% | 63.64% | 1350.00% | -218.00% | 5.08% |
| Change in YoY Net Profit Growth (%) | 0.00% | 151.51% | -59.60% | -151.19% | 21.11% | 205.78% | 10.74% | -25.25% | 1286.36% | -1568.00% | 223.08% |
Bilcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -12% |
| 5 Years: | -15% |
| 3 Years: | -2% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 14% |
| 3 Years: | 12% |
| TTM: | 27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| 1 Year: | 8% |
| Return on Equity | |
|---|---|
| 10 Years: | -39% |
| 5 Years: | -10% |
| 3 Years: | -5% |
| Last Year: | -5% |
Last Updated: September 5, 2025, 2:41 pm
Balance Sheet
Last Updated: September 10, 2025, 3:13 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves | 1,300 | 1,073 | 689 | 590 | 376 | -93 | 85 | 63 | 52 | 507 | 474 | 445 |
| Borrowings | 2,146 | 2,311 | 2,122 | 2,014 | 2,089 | 2,270 | 707 | 677 | 690 | 639 | 756 | 682 |
| Other Liabilities | 899 | 933 | 786 | 830 | 913 | 888 | 297 | 300 | 362 | 424 | 314 | 266 |
| Total Liabilities | 4,368 | 4,340 | 3,620 | 3,457 | 3,402 | 3,087 | 1,112 | 1,064 | 1,127 | 1,593 | 1,568 | 1,417 |
| Fixed Assets | 2,126 | 1,926 | 2,432 | 2,403 | 2,180 | 2,005 | 534 | 494 | 465 | 1,045 | 1,038 | 949 |
| CWIP | 262 | 218 | 161 | 149 | 170 | 79 | 0 | 0 | 1 | 1 | 1 | 4 |
| Investments | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 8 | 11 |
| Other Assets | 1,979 | 2,196 | 1,026 | 904 | 1,051 | 1,003 | 577 | 570 | 661 | 545 | 521 | 453 |
| Total Assets | 4,368 | 4,340 | 3,620 | 3,457 | 3,402 | 3,087 | 1,112 | 1,064 | 1,127 | 1,593 | 1,568 | 1,417 |
Below is a detailed analysis of the balance sheet data for Bilcare Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 24.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 24.00 Cr..
- For Reserves, as of Mar 2025, the value is 445.00 Cr.. The value appears to be declining and may need further review. It has decreased from 474.00 Cr. (Mar 2024) to 445.00 Cr., marking a decrease of 29.00 Cr..
- For Borrowings, as of Mar 2025, the value is 682.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 756.00 Cr. (Mar 2024) to 682.00 Cr., marking a decrease of 74.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 266.00 Cr.. The value appears to be improving (decreasing). It has decreased from 314.00 Cr. (Mar 2024) to 266.00 Cr., marking a decrease of 48.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,417.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,568.00 Cr. (Mar 2024) to 1,417.00 Cr., marking a decrease of 151.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 949.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,038.00 Cr. (Mar 2024) to 949.00 Cr., marking a decrease of 89.00 Cr..
- For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 4.00 Cr., marking an increase of 3.00 Cr..
- For Investments, as of Mar 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 11.00 Cr., marking an increase of 3.00 Cr..
- For Other Assets, as of Mar 2025, the value is 453.00 Cr.. The value appears to be declining and may need further review. It has decreased from 521.00 Cr. (Mar 2024) to 453.00 Cr., marking a decrease of 68.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,417.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,568.00 Cr. (Mar 2024) to 1,417.00 Cr., marking a decrease of 151.00 Cr..
However, the Borrowings (682.00 Cr.) are higher than the Reserves (445.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 241.00 | 184.00 | 205.00 | 188.00 | 159.00 | 168.00 | -662.00 | -626.00 | -630.00 | -582.00 | -717.00 | -637.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 105 | 125 | 35 | 29 | 38 | 38 | 22 | 90 | 95 | 70 | 73 | 55 |
| Inventory Days | 103 | 105 | 108 | 84 | 90 | 82 | 28 | 90 | 83 | 42 | 77 | 80 |
| Days Payable | 76 | 93 | 86 | 81 | 102 | 71 | 35 | 93 | 102 | 77 | 70 | 57 |
| Cash Conversion Cycle | 132 | 137 | 57 | 32 | 25 | 49 | 15 | 88 | 76 | 34 | 80 | 78 |
| Working Capital Days | 114 | 125 | 5 | -11 | -150 | -156 | -2 | -19 | -10 | -10 | 12 | -5 |
| ROCE % | 3% | 1% | 2% | 2% | -8% | -6% | -9% | 3% | 3% | 3% | 1% | 1% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -12.23 | -14.12 | 6.39 | -5.35 | -8.95 |
| Diluted EPS (Rs.) | -12.23 | -14.12 | 6.39 | -5.35 | -8.95 |
| Cash EPS (Rs.) | -4.37 | -5.77 | 37.38 | 14.82 | 14.59 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 199.21 | 274.44 | 161.27 | 68.51 | 69.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 199.21 | 274.44 | 298.99 | 68.51 | 69.74 |
| Revenue From Operations / Share (Rs.) | 334.69 | 317.34 | 416.87 | 358.76 | 264.48 |
| PBDIT / Share (Rs.) | 26.79 | 26.19 | 28.45 | 31.86 | 29.45 |
| PBIT / Share (Rs.) | 7.30 | 7.10 | 12.39 | 15.18 | 10.12 |
| PBT / Share (Rs.) | -30.30 | -30.45 | 83.28 | -1.79 | -10.60 |
| Net Profit / Share (Rs.) | -23.86 | -24.86 | 21.32 | -1.85 | -4.74 |
| NP After MI And SOA / Share (Rs.) | -12.23 | -14.12 | 6.39 | -5.35 | -8.95 |
| PBDIT Margin (%) | 8.00 | 8.25 | 6.82 | 8.87 | 11.13 |
| PBIT Margin (%) | 2.18 | 2.23 | 2.97 | 4.23 | 3.82 |
| PBT Margin (%) | -9.05 | -9.59 | 19.97 | -0.50 | -4.00 |
| Net Profit Margin (%) | -7.12 | -7.83 | 5.11 | -0.51 | -1.79 |
| NP After MI And SOA Margin (%) | -3.65 | -4.44 | 1.53 | -1.49 | -3.38 |
| Return on Networth / Equity (%) | -6.14 | -6.67 | 7.29 | -16.75 | -24.42 |
| Return on Capital Employeed (%) | 1.59 | 1.37 | 2.32 | 4.93 | 3.17 |
| Return On Assets (%) | -2.03 | -2.12 | 0.94 | -1.11 | -1.98 |
| Long Term Debt / Equity (X) | 0.96 | 1.09 | 2.49 | 7.14 | 6.14 |
| Total Debt / Equity (X) | 1.43 | 1.52 | 3.09 | 9.18 | 7.85 |
| Asset Turnover Ratio (%) | 0.52 | 0.47 | 0.72 | 0.43 | 0.29 |
| Current Ratio (X) | 1.01 | 1.17 | 1.01 | 1.04 | 1.08 |
| Quick Ratio (X) | 0.66 | 0.87 | 0.76 | 0.70 | 0.75 |
| Inventory Turnover Ratio (X) | 7.06 | 5.47 | 6.44 | 3.73 | 3.31 |
| Interest Coverage Ratio (X) | 0.76 | 0.75 | 1.12 | 1.09 | 0.91 |
| Interest Coverage Ratio (Post Tax) (X) | 0.39 | 0.36 | -1.94 | 0.51 | 0.49 |
| Enterprise Value (Cr.) | 991.34 | 998.83 | 881.91 | 900.48 | 834.43 |
| EV / Net Operating Revenue (X) | 1.26 | 1.34 | 0.89 | 1.07 | 1.34 |
| EV / EBITDA (X) | 15.72 | 16.20 | 13.16 | 12.01 | 12.03 |
| MarketCap / Net Operating Revenue (X) | 0.27 | 0.17 | 0.10 | 0.19 | 0.21 |
| Price / BV (X) | 0.46 | 0.26 | 0.49 | 2.19 | 1.57 |
| Price / Net Operating Revenue (X) | 0.27 | 0.17 | 0.10 | 0.19 | 0.21 |
| EarningsYield | -0.13 | -0.25 | 0.14 | -0.07 | -0.15 |
After reviewing the key financial ratios for Bilcare Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -12.23. This value is below the healthy minimum of 5. It has increased from -14.12 (Mar 24) to -12.23, marking an increase of 1.89.
- For Diluted EPS (Rs.), as of Mar 25, the value is -12.23. This value is below the healthy minimum of 5. It has increased from -14.12 (Mar 24) to -12.23, marking an increase of 1.89.
- For Cash EPS (Rs.), as of Mar 25, the value is -4.37. This value is below the healthy minimum of 3. It has increased from -5.77 (Mar 24) to -4.37, marking an increase of 1.40.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 199.21. It has decreased from 274.44 (Mar 24) to 199.21, marking a decrease of 75.23.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 199.21. It has decreased from 274.44 (Mar 24) to 199.21, marking a decrease of 75.23.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 334.69. It has increased from 317.34 (Mar 24) to 334.69, marking an increase of 17.35.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 26.79. This value is within the healthy range. It has increased from 26.19 (Mar 24) to 26.79, marking an increase of 0.60.
- For PBIT / Share (Rs.), as of Mar 25, the value is 7.30. This value is within the healthy range. It has increased from 7.10 (Mar 24) to 7.30, marking an increase of 0.20.
- For PBT / Share (Rs.), as of Mar 25, the value is -30.30. This value is below the healthy minimum of 0. It has increased from -30.45 (Mar 24) to -30.30, marking an increase of 0.15.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -23.86. This value is below the healthy minimum of 2. It has increased from -24.86 (Mar 24) to -23.86, marking an increase of 1.00.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -12.23. This value is below the healthy minimum of 2. It has increased from -14.12 (Mar 24) to -12.23, marking an increase of 1.89.
- For PBDIT Margin (%), as of Mar 25, the value is 8.00. This value is below the healthy minimum of 10. It has decreased from 8.25 (Mar 24) to 8.00, marking a decrease of 0.25.
- For PBIT Margin (%), as of Mar 25, the value is 2.18. This value is below the healthy minimum of 10. It has decreased from 2.23 (Mar 24) to 2.18, marking a decrease of 0.05.
- For PBT Margin (%), as of Mar 25, the value is -9.05. This value is below the healthy minimum of 10. It has increased from -9.59 (Mar 24) to -9.05, marking an increase of 0.54.
- For Net Profit Margin (%), as of Mar 25, the value is -7.12. This value is below the healthy minimum of 5. It has increased from -7.83 (Mar 24) to -7.12, marking an increase of 0.71.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -3.65. This value is below the healthy minimum of 8. It has increased from -4.44 (Mar 24) to -3.65, marking an increase of 0.79.
- For Return on Networth / Equity (%), as of Mar 25, the value is -6.14. This value is below the healthy minimum of 15. It has increased from -6.67 (Mar 24) to -6.14, marking an increase of 0.53.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 10. It has increased from 1.37 (Mar 24) to 1.59, marking an increase of 0.22.
- For Return On Assets (%), as of Mar 25, the value is -2.03. This value is below the healthy minimum of 5. It has increased from -2.12 (Mar 24) to -2.03, marking an increase of 0.09.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.96. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 0.96, marking a decrease of 0.13.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.43. This value exceeds the healthy maximum of 1. It has decreased from 1.52 (Mar 24) to 1.43, marking a decrease of 0.09.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.52. It has increased from 0.47 (Mar 24) to 0.52, marking an increase of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 1.5. It has decreased from 1.17 (Mar 24) to 1.01, marking a decrease of 0.16.
- For Quick Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has decreased from 0.87 (Mar 24) to 0.66, marking a decrease of 0.21.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.06. This value is within the healthy range. It has increased from 5.47 (Mar 24) to 7.06, marking an increase of 1.59.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 3. It has increased from 0.75 (Mar 24) to 0.76, marking an increase of 0.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 3. It has increased from 0.36 (Mar 24) to 0.39, marking an increase of 0.03.
- For Enterprise Value (Cr.), as of Mar 25, the value is 991.34. It has decreased from 998.83 (Mar 24) to 991.34, marking a decrease of 7.49.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.26, marking a decrease of 0.08.
- For EV / EBITDA (X), as of Mar 25, the value is 15.72. This value exceeds the healthy maximum of 15. It has decreased from 16.20 (Mar 24) to 15.72, marking a decrease of 0.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 24) to 0.27, marking an increase of 0.10.
- For Price / BV (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.26 (Mar 24) to 0.46, marking an increase of 0.20.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 24) to 0.27, marking an increase of 0.10.
- For EarningsYield, as of Mar 25, the value is -0.13. This value is below the healthy minimum of 5. It has increased from -0.25 (Mar 24) to -0.13, marking an increase of 0.12.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bilcare Ltd:
- Net Profit Margin: -7.12%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.59% (Industry Average ROCE: 12.76%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -6.14% (Industry Average ROE: 24.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.39
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.66
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 66.32)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.43
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -7.12%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Packaging & Containers | 1028, Shiroli, Rajgurunagar, Pune Maharashtra 410505 | cs@bilcare.com www.bilcare.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Shreyans Bhandari | Chairman & Managing Director |
| Ms. Kavita Bhansali | Executive Director |
| Mr. Rajesh Devene | Independent Director |
| Mrs. Madhuri Vaidya | Independent Director |
| Ms. Alka Sagar | Independent Director |
FAQ
What is the intrinsic value of Bilcare Ltd?
Bilcare Ltd's intrinsic value (as of 09 November 2025) is 135.92 which is 35.92% higher the current market price of 100.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 236 Cr. market cap, FY2025-2026 high/low of 116/51.1, reserves of ₹445 Cr, and liabilities of 1,417 Cr.
What is the Market Cap of Bilcare Ltd?
The Market Cap of Bilcare Ltd is 236 Cr..
What is the current Stock Price of Bilcare Ltd as on 09 November 2025?
The current stock price of Bilcare Ltd as on 09 November 2025 is 100.
What is the High / Low of Bilcare Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bilcare Ltd stocks is 116/51.1.
What is the Stock P/E of Bilcare Ltd?
The Stock P/E of Bilcare Ltd is .
What is the Book Value of Bilcare Ltd?
The Book Value of Bilcare Ltd is 199.
What is the Dividend Yield of Bilcare Ltd?
The Dividend Yield of Bilcare Ltd is 0.00 %.
What is the ROCE of Bilcare Ltd?
The ROCE of Bilcare Ltd is 1.10 %.
What is the ROE of Bilcare Ltd?
The ROE of Bilcare Ltd is 5.58 %.
What is the Face Value of Bilcare Ltd?
The Face Value of Bilcare Ltd is 10.0.